Françoise Brucker-Davis1, Patricia Panaïa-Ferrari2, Jocelyn Gal3, Patrick Fénichel1, Sylvie Hiéronimus4. 1. Department of Endocrinology, Diabetology and Reproductive Medicine, Nice, France ; Institut National de la Recherche Médicale, UMR U895, Université Nice-Sophia Antipolis, Nice, France. 2. Department of Biochemistry, UMR U895, Université Nice-Sophia Antipolis, Nice, France. 3. Department of Biostatistics, CHU de Nice, UMR U895, Université Nice-Sophia Antipolis, Nice, France. 4. Department of Endocrinology, Diabetology and Reproductive Medicine, Nice, France.
Abstract
OBJECTIVES: The aim of the study was to determine the evolution of thyroid tests throughout pregnancy and postpartum in healthy women with and without iodine supplementation. METHODS: This was a prospective, randomized, interventional study of iodine supplementation (150 μg/day) from the first trimester until 3 months postpartum versus controls. 111 pregnant women with normal initial thyroid tests were enrolled, undergoing comprehensive thyroid assessment at each trimester. We present results of longitudinal and cross-sectional analyses. RESULTS: Initial ioduria suggested mild iodine deficiency in both groups, while third-trimester ioduria rose to levels of iodine sufficiency in the iodine-supplemented group. In the longitudinal study, free T4 (FT4) levels decreased in the second and third trimesters compared to the first trimester in both groups, with no change in TSH, and rose postpartum, though lower than the first trimester. FT3 levels and the total T4 (TT4)/thyroxine-binding globulin (TBG) ratio followed the same evolution as FT4. TT4 levels rose due to TBG increase. Thyroglobulin (Tg) of iodine group remained stable, contrasting with the rise in the control group. In the cross-sectional study, there was no difference between the two groups in thyroid tests at any time-point, except for lower Tg in the second trimester and postpartum visits in the iodine group. CONCLUSIONS:In healthy, mildly iodine-deficient pregnant women, a 'drop' of FT4 and TT4/TBG without TSH increase occurs between the first and second trimesters, and is not prevented by iodine supplementation, suggesting physiology. Therefore, FT4 is valuable to assess thyroid function in pregnancy in clinical practice with appropriate trimester-specific reference range. It brings up reflection on threshold for diagnosis and treatment of hypothyroxinemia.
RCT Entities:
OBJECTIVES: The aim of the study was to determine the evolution of thyroid tests throughout pregnancy and postpartum in healthy women with and without iodine supplementation. METHODS: This was a prospective, randomized, interventional study of iodine supplementation (150 μg/day) from the first trimester until 3 months postpartum versus controls. 111 pregnant women with normal initial thyroid tests were enrolled, undergoing comprehensive thyroid assessment at each trimester. We present results of longitudinal and cross-sectional analyses. RESULTS: Initial ioduria suggested mild iodinedeficiency in both groups, while third-trimester ioduria rose to levels of iodine sufficiency in the iodine-supplemented group. In the longitudinal study, free T4 (FT4) levels decreased in the second and third trimesters compared to the first trimester in both groups, with no change in TSH, and rose postpartum, though lower than the first trimester. FT3 levels and the total T4 (TT4)/thyroxine-binding globulin (TBG) ratio followed the same evolution as FT4. TT4 levels rose due to TBG increase. Thyroglobulin (Tg) of iodine group remained stable, contrasting with the rise in the control group. In the cross-sectional study, there was no difference between the two groups in thyroid tests at any time-point, except for lower Tg in the second trimester and postpartum visits in the iodine group. CONCLUSIONS: In healthy, mildly iodine-deficient pregnant women, a 'drop' of FT4 and TT4/TBG without TSH increase occurs between the first and second trimesters, and is not prevented by iodine supplementation, suggesting physiology. Therefore, FT4 is valuable to assess thyroid function in pregnancy in clinical practice with appropriate trimester-specific reference range. It brings up reflection on threshold for diagnosis and treatment of hypothyroxinemia.
Authors: Jens Henrichs; Jacoba J Bongers-Schokking; Jacqueline J Schenk; Akhgar Ghassabian; Henk G Schmidt; Theo J Visser; Herbert Hooijkaas; Sabine M P F de Muinck Keizer-Schrama; Albert Hofman; Vincent V W Jaddoe; Willy Visser; Eric A P Steegers; Frank C Verhulst; Yolanda B de Rijke; Henning Tiemeier Journal: J Clin Endocrinol Metab Date: 2010-06-09 Impact factor: 5.958
Authors: Ellen Anckaert; Kris Poppe; Katleen Van Uytfanghe; Johan Schiettecatte; Walter Foulon; Linda M Thienpont Journal: Clin Chim Acta Date: 2010-05-25 Impact factor: 3.786
Authors: R Romano; E A Jannini; M Pepe; A Grimaldi; M Olivieri; P Spennati; F Cappa; M D'Armiento Journal: Am J Obstet Gynecol Date: 1991-02 Impact factor: 8.661
Authors: Richard H Lee; Carole A Spencer; Jorge H Mestman; Erin A Miller; Ivana Petrovic; Lewis E Braverman; T Murphy Goodwin Journal: Am J Obstet Gynecol Date: 2008-12-27 Impact factor: 8.661
Authors: David Gyllenberg; Andre Sourander; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Ian W McKeague; Alan S Brown Journal: Biol Psychiatry Date: 2015-06-19 Impact factor: 13.382
Authors: Kimberly B Harding; Juan Pablo Peña-Rosas; Angela C Webster; Constance My Yap; Brian A Payne; Erika Ota; Luz Maria De-Regil Journal: Cochrane Database Syst Rev Date: 2017-03-05
Authors: Sarah C Bath; Victor J M Pop; Victoria L Furmidge-Owen; Maarten A C Broeren; Margaret P Rayman Journal: Thyroid Date: 2016-11-18 Impact factor: 6.568
Authors: Sofia Manousou; Maria Andersson; Robert Eggertsen; Sandra Hunziker; Lena Hulthén; Helena Filipsson Nyström Journal: Eur J Nutr Date: 2019-10-15 Impact factor: 5.614
Authors: Sofia Manousou; Birgitta Johansson; Anna Chmielewska; Janna Eriksson; Kerstin Gutefeldt; Carl-Johan Tornhage; Robert Eggertsen; Helge Malmgren; Lena Hulthen; Magnus Domellöf; Helena Nystrom Filipsson Journal: BMJ Open Date: 2018-04-10 Impact factor: 2.692
Authors: Nicole J E Verhagen; Sueppong Gowachirapant; Pattanee Winichagoon; Maria Andersson; Alida Melse-Boonstra; Michael B Zimmermann Journal: Front Endocrinol (Lausanne) Date: 2020-10-06 Impact factor: 5.555